CompletedNCT01342380
Genetic and Metabolic Features During Mood-Treatment Studies
About this title
Read the official source — NCT01342380Observational studyAges 18–70United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- ClevelandSee all locations and recruitment
Study information
Study start dateFebruary 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 42
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT01342380
- Official title
Show the full official title
Pharmacogenetic Study of Pioglitazone and Quetiapine XR Treatment Response in Mood Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Who was this study for?
Listed age limits: 18 years to 70 years.
